1,502
Participants
Start Date
May 1, 2009
Primary Completion Date
December 13, 2010
Study Completion Date
December 13, 2010
Gestodene/EE Patch (BAY86-5016)
55 mg ethinyl estradiol \& 2.1 mg gestodene, 21 days for 13 cycles
New York
Pittsburgh
Philadelphia
Norfolk
Winston-Salem
New Bern
Columbia
Mt. Pleasant
Decatur
Roswell
Atlanta
Jacksonville
Pembroke Pines
Miami
Meridien Research, St. Petersburg
Birmingham
Nashville
Nashville
Chattanooga
Knoxville
Women's Care Center, PLC, Memphis
Columbus
Cleveland
South Bend
Newburgh
Chaska
Chicago
Lincoln
Marrero
York Clinical Consulting, Oklahoma City
Practice Research Organization, Dallas
Advances in Health, inc., Houston
The Woman's Hospital of Texas, Houston
Corpus Christi
Littleton
Denver
Rosemark Women Care Specialist, Idaho Falls
Research Associates, Boise
Precision Trials, Phoenix
Glendale
Visions Clinical Research - Tucson, Tucson
Albuquerque
Las Vegas
Las Vegas
Office of Dr. R. Garn Mabey, MD, Las Vegas
Pacific Palisades
Torrance
Paramount
Genesis Center for Clinical Research, San Diego
San Diego
San Diego
Santa Ana
Carmichael
Eugene
Women's Clinical Research Center, Seattle
New London
Visions Clinical Research, Boynton Beach
Boston
Lawrenceville
Moorestown
Cincinnati
Portland
Warwick
Lead Sponsor
Bayer
INDUSTRY